← Back to Clinical Trials
Recruiting NCT07344077

NCT07344077 Comparing Outcomes Using 1 Versus 2 Kirshner Wire Fixation in Patients With Severe Hallux Valgus

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07344077
Status Recruiting
Phase
Sponsor Queen Savang Vadhana Memorial Hospital, Thailand
Condition Hallux Valgus Correction
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-06-01
Primary Completion 2026-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
2 Kirshner wire fixation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2024-06-01 with a primary completion date of 2026-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Comparing the radiographic and functional outcomes by using a Minimal invasive procedure to treat Hallux Valgus ; Distal linear Metatarsal Osteotomy - 1 Kirshner wire fixation versus two Kirshner wire fixation

Eligibility Criteria

Inclusion Criteria: * age 18-60 year * pain along medial surface of first MTP joint * radiographic finding : medial deviation of first Metatarsal bone , and lateral deviation of Big toe * complete a follow up period of 1 year , filling questionaires and undergone radiographic examination every visit * radiographic finding : Hallux valgus angle \>20 , Intermetatarsal angle \> 10 degrees * failed conservative treatment for atleast 8 months , with persistent pain along medial eminence and having difficulty walking, bearing weight Exclusion Criteria: * previous injury/fracture at big toe * deviation/ subluxation of 1st MTP joint from traumatic event * arthritic change of metatarsal bone, phalangeal bone of big toe * previous/active infection , open wound along first metatarsal and big toe * patient denied enrolling in study

Contact & Investigator

Central Contact

Krit Patana-anake, M.D.

✉ mead.patana@gmail.com

📞 +66849404004

Frequently Asked Questions

Who can join the NCT07344077 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Hallux Valgus Correction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07344077 currently recruiting?

Yes, NCT07344077 is actively recruiting participants. Contact the research team at mead.patana@gmail.com for enrollment information.

Where is the NCT07344077 trial being conducted?

This trial is being conducted at Chon Buri, Thailand.

Who is sponsoring the NCT07344077 clinical trial?

NCT07344077 is sponsored by Queen Savang Vadhana Memorial Hospital, Thailand. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology